D. Palliser

发表

Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors

Judy Lieberman, Dipanjan Chowdhury, Deborah Palliser, 2005, Nature Biotechnology.

Lentivirus-delivered stable gene silencing by RNAi in primary cells.

William C Hahn, David M Sabatini, Phillip A Sharp, 2003, RNA.

Delivery of siRNAs to Dendritic Cells Using DEC205-Targeted Lipid Nanoparticles to Inhibit Immune Responses

Keith E Maier, Keith E. Maier, M. Levy, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

Myeloid Differentiation Factor 88 Is Required for Cross-Priming In Vivo1

H. Ploegh, M. Boes, D. Palliser, 2004, The Journal of Immunology.

Required for Cross-Priming In Vivo Myeloid Differentiation Factor 88 Is

H. Ploegh, M. Boes, D. Palliser, 2004 .

Multiple Intracellular Routes in the Cross-Presentation of a Soluble Protein by Murine Dendritic Cells1

D. Palliser, E. Guillén, H. Eisen, 2005, The Journal of Immunology.

Induction of Tolerance via the Respiratory Mucosa

Gareth A. Stewart, J. Lamb, J. Lowrey, 1998, International Archives of Allergy and Immunology.

Targeting Liposomes to Immune Cells

M. Levy, D. Palliser, 2015 .

RNA Interference in Mouse Models

J. Lieberman, L. Parijs, Erwei Song, 2004 .

A General RNA Motif for Cellular Transfection

Amy C Yan, M. Levy, A. Ellington, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Cross-Presentation of a Soluble Protein by Multiple Intracellular Routes in the

D. Palliser, E. Guillén, Mindy Ju, 2013 .

Murine Dendritic Cells Cross-Presentation of a Soluble Protein by Multiple Intracellular Routes in the Eisen

D. Palliser, E. Guillén, H. Eisen, 2005 .

Tandem peptide epitopes facilitate CD4‐dependent activation of T cell clones

J. Lamb, D. Palliser, J. Hayball, 1997, Immunology and cell biology.

A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins.

R. Young, D. Palliser, E. Guillén, 2000, Immunity.

Homeostatic T cell proliferation in a T cell-dendritic cell coculture system

Jianzhu Chen, Q. Ge, D. Palliser, 2002, Proceedings of the National Academy of Sciences of the United States of America.

siRNA-based topical microbicides targeting sexually transmitted diseases

D. Palliser, Joseph A. Katakowski, 2012 .

How do cultured CD8(+) murine T cell clones survive repeated ligation of the TCR?

Jianzhu Chen, D. Palliser, H. Eisen, 2002, International immunology.

Unraveling the mechanisms by which heat shock proteins activate the immune system.

D. Palliser, 2001, Current opinion in molecular therapeutics.

A Role for Toll-Like Receptor 4 in Dendritic Cell Activation and Cytolytic CD8 T Cell Differentiation in Response to a Recombinant Heat Shock Fusion Protein

N. Hacohen, R. Young, D. Palliser, 2004 .

Shock Fusion Protein Recombinant Differentiation in Response to a T Cell + Cell Activation and Cytolytic CD8 A Role for Toll-Like Receptor 4 in Dendritic

N. Hacohen, R. Young, D. Palliser, 2004 .

Chemoattractants provoke monocyte adhesion to human mesangial cells and mesangial cell injury.

B. Brenner, W. Jiménez, M. Denton, 1992, Kidney international.

CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.

K. Rock, A. Berezovskaya, D. Palliser, 1998, Journal of immunology.

Transgenic Mice Class I and Class II Expression in Ly-6 A . 2 T Cells Mature in the Absence of MHC + CD 4

K. Rock, A. Berezovskaya, C. Henderson, 1998 .

Regulated expression of Ly-6A.2 is important for T cell development.

K. Rock, E. Lacy, A. Berezovskaya, 1995, Journal of immunology.

T-cell response to inhaled antigen.

J. Lamb, J. Lowrey, G. Hoyne, 1998, Chemical immunology.

Memory-T-cell-derived interferon-γ instructs potent innate cell activation for protective immunity.

D. Palliser, G. Lauvau, S. Soudja, 2014, Immunity.

Evolutionarily conserved genetic interactions with budding and fission yeast MutS identify orthologous relationships in mismatch repair-deficient cancer cells

N. Krogan, M. Shales, A. Roguev, 2014, Genome Medicine.

An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection

J. Lieberman, R. Bronson, D. Knipe, 2006, Nature.

The silent treatment: siRNAs as small molecule drugs

J. Lieberman, D. Dykxhoorn, D. Palliser, 2006, Gene Therapy.

Durable protection from Herpes Simplex Virus-2 transmission following intravaginal application of siRNAs targeting both a viral and host gene.

J. Lieberman, M. Manoharan, Yichao Wu, 2009, Cell host & microbe.

A Role for Toll-Like Receptor 4 in Dendritic Cell Activation and Cytolytic CD8+ T Cell Differentiation in Response to a Recombinant Heat Shock Fusion Protein1

N. Hacohen, R. Young, D. Palliser, 2004, The Journal of Immunology.

Delivery Strategies for Developing siRNA-Based Vaginal Microbicides

D. Palliser, Joseph A. Katakowski, 2014 .

Listeria-Infected Myeloid Dendritic Cells Produce IFN-β, Priming T Cell Activation 1

J. Lieberman, Pengcheng Zhu, Ann Schlesinger, 2005, The Journal of Immunology.

A Peptide That Antagonizes TCR-Mediated Reactions with Both Syngeneic and Allogeneic Agonists: Functional and Structural Aspects1

Qing Ge, Markus G. Rudolph, Herman N. Eisen, 2004, The Journal of Immunology.

Structural Aspects Allogeneic Agonists: Functional and Reactions with Both Syngeneic and a Peptide That Antagonizes Tcr-mediated

J. Luz, M. Rudolph, Jianzhu Chen, 2022 .

Aptamer-targeted Antigen Delivery

S. Almo, M. Levy, D. Palliser, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Distinct cathepsins control necrotic cell death mediated by pyroptosis inducers and lysosome-destabilizing agents

K. Chandran, M. Lisanti, D. Palliser, 2015, Cell cycle.

Optimizing siRNA delivery to the genital mucosa.

D. Palliser, Joseph A. Katakowski, 2011, Discovery medicine.

siRNA-based topical microbicides targeting sexually transmitted infections.

D. Palliser, Joseph A. Katakowski, 2010, Current opinion in molecular therapeutics.

Memory T cell-derived IFN-gamma instructs potent innate cell activation for protective immunity (INC6P.349)

D. Palliser, G. Lauvau, S. Soudja, 2014, The Journal of Immunology.

The silent treatment: siRNAs as small molecule drugs

J. Lieberman, D. Dykxhoorn, D. Palliser, 2006, Gene Therapy.

Allogeneic Agonists: Functional and Reactions with Both Syngeneic and A Peptide That Antagonizes TCR-Mediated

D. Palliser, C. McKinley, S. Lamontagne, 2004 .

Durable protection from Herpes Simplex Virus-2 transmission following intravaginal application of siRNAs targeting both a viral and host gene.

J. Lieberman, M. Manoharan, Yichao Wu, 2009, Cell host & microbe.